Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome makes decreases

.After increasing $213 thousand in 2023-- one of the year's most extensive private biotech shots-- V...

BioMarin creates director group along with biotech veterinarians-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, firings and al...

Biopharma Q2 VC attacked highest level since '22, while M&ampA decreased

.Financial backing funding into biopharma cheered $9.2 billion throughout 215 handle the second four...

Bicara, Zenas seek IPOs to drive late-phase resources toward market

.Bicara Therapeutics and also Zenas Biopharma have actually delivered clean motivation to the IPO ma...

Genentech to shut cancer cells immunology research division

.Genentech will shut its own cancer cells immunology analysis department, and device mind and well-k...

Kezar goes down sound lump yet to prove its truly worth in period 1 test

.Kezar Life Sciences is actually dropping its dim phase 1 sound tumor medication as the biotech goes...

Acelyrin drops izokibep, lays off 3rd of personnel

.Even with izokibep sustaining its newly found winning streak in the facility, Acelyrin is no more p...

Rivus' phase 2 obesity-related heart failure test strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid standstills preclinical job, IV plan after soticlestat neglect

.Ovid Rehab already disclosed final month that it was actually trimming its own headcount as the com...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened up a $700 million R&ampD center in the Boston Seaport, enhancing its RNA and a...